Consumer Discretionary • Specialty Chemicals
$153.73 ▼ -0.33
(-0.21%)
MKT CAP: $3.20B • VOL: 103.6K
52W L $116 52W H $174
HWKN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-29 | FY 2024
FILED 2025-03-30 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.08B | $974.4M | $919.2M |
| YoY Revenue Growth % | +11.2% | +6.0% | — |
| Gross Profit | $245.1M | $225.5M | — |
| Gross Margin % | 22.6% | 23.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $121.3M | $119.2M | $104.0M |
| Operating Margin % | 11.2% | 12.2% | 11.3% |
| Net Income (GAAP) | $81.5M | $84.3M | $75.4M |
| EBITDA (Normalized) | $167.9M | $152.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $144.3M | $111.1M | $159.5M |
| Capital Expenditures (CapEx) | $58.2M | $41.1M | — |
| Free Cash Flow (FCF) | $86.1M | $70.0M | $159.5M |
| FCF Margin % | 7.9% | 7.2% | 17.4% |
| Return on Invested Capital (ROIC %) | 12.4% | 16.8% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $253.4M | $103.9M | — |
| Total Stockholders' Equity | $518.9M | $457.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HWKN.